Content by ERS Genomics
|1 min read
ERS Genomics Announces Agreement with Applied StemCell to Commercialize CRISPR Gene Editing Services and Reagents
ERS Genomics holds an exclusive worldwide license from Dr. Charpentier to the foundational patents covering CRISPR/Cas9Page 1 of 1




